Clostridium Difficile and Inflammatory Bowel Disease

被引：49
|
作者：
Ananthakrishnan, Ashwin N. [2 ]
Issa, Mazen [2 ]
Binion, David G. [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, UPMC IBD Ctr, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA
[2] Med Coll Wisconsin, Div Gastroenterol & Hepatol, Milwaukee, WI 53226 USA
来源：
GASTROENTEROLOGY CLINICS OF NORTH AMERICA | 2009年 / 38卷 / 04期
关键词：
Clostridium difficile; Inflammatory bowel disease; Crohn disease; Ulcerative colitis; Colectomy; TOXIN-A; PSEUDOMEMBRANOUS COLITIS; RISK-FACTORS; DIARRHEA; INFECTION; VANCOMYCIN; METRONIDAZOLE; DIAGNOSIS; ENTERITIS; OUTBREAK;
D O I：
10.1016/j.gtc.2009.07.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The past decade has seen an alarming increase in the burden of disease associated with Clostridium difficile. Several studies have now demonstrated an increasing incidence of C difficile infection in patients with inflammatory bowel disease (IBD) with a more severe course of disease compared with the non-IBD population. This article summarizes the available literature on the impact of C difficile infection on IBD and discusses the various diagnostic testing and treatment options available. Also reviewed are clinical situations specific to patients with IBD that are important for the treating physician to recognize.
引用
收藏
页码：711 / +
页数：19
相关论文
共 50 条
  • [41] More Bad News on Clostridium difficile in Inflammatory Bowel Disease
    HeaSeo, Da
    Stone, Christian D.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (04) : 641 - 642
  • [42] Pathology of Clostridium difficile colitis in the inflammatory bowel disease patient
    Rowe, J. Jordi
    Komorowski, Richard
    Binion, David
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 126 (04) : 661 - 661
  • [43] Recent developments on the role of Clostridium difficile in inflammatory bowel disease
    Hugh James Freeman
    World Journal of Gastroenterology, 2008, (18) : 2794 - 2796
  • [44] Recurrent Clostridium difficile colitis in inflammatory bowel disease patients
    Issa, Mazen
    Weber, Lydia R.
    Kanaa, Yasmin
    Emmons, Jeanne
    Skaros, Susan
    Knox, Joshua F.
    Otterson, Mary F.
    Binion, David G.
    GASTROENTEROLOGY, 2007, 132 (04) : A660 - A660
  • [45] Recent developments on the role of Clostridium difficile in inflammatory bowel disease
    Freeman, Hugh James
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (18) : 2794 - 2796
  • [46] Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease
    Dai, Cong
    Jiang, Min
    Sun, Ming-Jun
    GASTROENTEROLOGY, 2018, 154 (01) : 256 - 256
  • [47] Bezlotoxumab for Clostridium difficile Infection Complicating Inflammatory Bowel Disease
    Kelly, Ciaran P.
    Wilcox, Mark H.
    Glerup, Henning
    Aboo, Nazimuddin
    Ellison, Misoo C.
    Eves, Karen
    Dorr, Mary Beth
    GASTROENTEROLOGY, 2018, 155 (04) : 1270 - 1271
  • [48] Impact of Clostridium difficile Infection on Pediatric Inflammatory Bowel Disease
    Pascarella, Filomena
    Martinelli, Massimo
    Miele, Erasmo
    Del Pezzo, Mariassunta
    Roscetto, Emanuela
    Staiano, Annamaria
    JOURNAL OF PEDIATRICS, 2009, 154 (06): : 854 - 858
  • [49] Microbiota insights in Clostridium difficile infection and inflammatory bowel disease
    Rodriguez, C.
    Romero, E.
    Garrido-Sanchez, L.
    Alcain-Martinez, G.
    Andrade, R. J.
    Taminiau, B.
    Daube, G.
    Garcia-Fuentes, E.
    GUT MICROBES, 2020, 12 (01)
  • [50] Impact of Clostridium difficile infection on pediatric inflammatory bowel disease
    Pascarella, Filomena
    Miele, Erasmo
    Martinelli, Massimo
    Roscetto, Emanuela
    Del Pezzo, Mariassunta
    Rossano, Fabio
    Staiano, Annamaria
    GASTROENTEROLOGY, 2008, 134 (04) : A14 - A14
12345